Literature DB >> 19302176

The regulatory function of umbilical cord blood CD4(+) CD25(+) T cells stimulated with anti-CD3/anti-CD28 and exogenous interleukin (IL)-2 or IL-15.

Chen-Cheng Lee1, Syh-Jae Lin, Po-Jen Cheng, Ming-Ling Kuo.   

Abstract

The abundance of CD4(+) CD25(+) regulatory T cells in umbilical cord blood (UCB) might contribute to the decreased severity of graft-vs.-host disease (GVHD) for UCB transplantation. This study aims to characterize the phenotypes and suppressive function of UCB CD4(+) CD25(+) T cells under the influence of anti-CD3/anti-CD28 (CD3/CD28) and exogenous interleukin (IL)-2 or IL-15. Higher percentages of CD4(+) CD25(high) and FoxP3(+) cells were detected in UCB compared to their adult counterparts. IL-15 was as effective as IL-2 in enhancing the proliferation of CD3/CD28 stimulated UCB CD4(+) CD25(+) T cells. Phenotypically, IL-2/IL-15-stimulated UCB CD4(+) CD25(+) T cells expressed higher level of CTLA-4, GITR, membrane bound transforming growth factor-beta (mTGF-beta), and especially Foxp-3 than controls. IL-2/IL-15-stimulated UCB CD4(+) CD25(+) T cells also produced much higher IL-10 and TGF-beta than controls; while IL-2/IL-15-stimulated UCB CD4(+) CD25(-) T cells showed increased TGF-beta, but not IL-10 production. IL-2/IL-15-cultured UCB CD4(+) CD25(+) T cells showed comparable suppressor activity on allogeneic adult CD4(+) T-cell proliferation compared to controls, partly through a contact-dependent fashion. Taken together, IL-2/IL-15-stimulated UCB CD4(+) CD25(+) T cells show distinct regulatory T-cell phenotypic and functional features, and may be applied for the alleviation of GVHD severity following UCB transplantation.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19302176     DOI: 10.1111/j.1399-3038.2008.00843.x

Source DB:  PubMed          Journal:  Pediatr Allergy Immunol        ISSN: 0905-6157            Impact factor:   6.377


  12 in total

Review 1.  Umbilical cord blood immunology: relevance to stem cell transplantation.

Authors:  Syh-Jae Lin; Dah-Chin Yan; Yen-Chang Lee; Hsiu-Shan Hsiao; Pei-Tzu Lee; Yu-Wen Liang; Ming-Ling Kuo
Journal:  Clin Rev Allergy Immunol       Date:  2012-02       Impact factor: 8.667

Review 2.  Immune regulatory cells in umbilical cord blood and their potential roles in transplantation tolerance.

Authors:  Young-June Kim; Hal E Broxmeyer
Journal:  Crit Rev Oncol Hematol       Date:  2010-08-19       Impact factor: 6.312

3.  Cytokines as Adjuvants for Vaccine and Cellular Therapies for Cancer.

Authors:  Christian M Capitini; Terry J Fry; Crystal L Mackall
Journal:  Am J Immunol       Date:  2009-01-01

Review 4.  Umbilical cord blood graft engineering: challenges and opportunities.

Authors:  P A Thompson; K Rezvani; C M Hosing; B Oran; A L Olson; U R Popat; A M Alousi; N D Shah; S Parmar; C Bollard; P Hanley; P Kebriaei; L Cooper; J Kellner; I K McNiece; E J Shpall
Journal:  Bone Marrow Transplant       Date:  2015-06       Impact factor: 5.483

5.  Effect of chorioamnionitis on regulatory T cells in moderate/late preterm neonates.

Authors:  Cesar M Rueda; Casey B Wells; Tate Gisslen; Alan H Jobe; Suhas G Kallapur; Claire A Chougnet
Journal:  Hum Immunol       Date:  2014-11-08       Impact factor: 2.850

6.  Immune reconstitution after double umbilical cord blood stem cell transplantation: comparison with unrelated peripheral blood stem cell transplantation.

Authors:  Caron A Jacobson; Amin T Turki; Sean M McDonough; Kristen E Stevenson; Haesook T Kim; Grace Kao; Maria I Herrera; Carol G Reynolds; Edwin P Alyea; Vincent T Ho; John Koreth; Philippe Armand; Yi-Bin Chen; Karen Ballen; Robert J Soiffer; Joseph H Antin; Corey S Cutler; Jerome Ritz
Journal:  Biol Blood Marrow Transplant       Date:  2011-08-26       Impact factor: 5.742

7.  Targeting Aurora A kinase activity with the investigational agent alisertib increases the efficacy of cytarabine through a FOXO-dependent mechanism.

Authors:  Kevin R Kelly; Steffan T Nawrocki; Claudia M Espitia; Mengkun Zhang; Johnny J Yang; Swaminathan Padmanabhan; Jeffrey Ecsedy; Francis J Giles; Jennifer S Carew
Journal:  Int J Cancer       Date:  2012-06-28       Impact factor: 7.396

8.  Expansion of regulatory T cells from umbilical cord blood and adult peripheral blood CD4(+)CD25 (+) T cells.

Authors:  Syh-Jae Lin; Chun-Hao Lu; Dah-Chin Yan; Pei-Tzu Lee; Hsiu-Shan Hsiao; Ming-Ling Kuo
Journal:  Immunol Res       Date:  2014-10       Impact factor: 2.829

9.  TSLP directly impairs pulmonary Treg function: association with aberrant tolerogenic immunity in asthmatic airway.

Authors:  Khoa D Nguyen; Christopher Vanichsarn; Kari C Nadeau
Journal:  Allergy Asthma Clin Immunol       Date:  2010-03-15       Impact factor: 3.406

10.  Multiple unit pooled umbilical cord blood is a viable source of therapeutic regulatory T cells.

Authors:  Kate Milward; Fadi Issa; Joanna Hester; Daniel Figueroa-Tentori; Alejandro Madrigal; Kathryn J Wood
Journal:  Transplantation       Date:  2013-01-15       Impact factor: 4.939

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.